Monocyte cellular function in asthmatic patients on alternate-day steroid therapy

Area of Science:

• Immunology
• Pharmacology
• Respiratory Medicine

Background:

• Alternate-day steroid therapy is a common regimen for managing asthma.
• Understanding the impact of such therapy on immune cell function is crucial for patient safety.
• Previous studies have shown varied effects of corticosteroids on immune cells.

Purpose of the Study:

• To investigate the effects of alternate-day steroid therapy on monocyte cellular function in asthma patients.
• To assess changes in monocyte chemotaxis, bacterial killing, phagocytosis, and oil phagocytosis.
• To evaluate alterations in circulating white blood cell populations following steroid administration.

Main Methods:

• Studied 15 asthma patients on alternate-day prednisone (45.4 +/- 17.45 mg qod) and 16 healthy controls.
• Monocyte function tests (chemotaxis, bacterial killing, phagocytosis) were performed at specific time points post-steroid dose.
• Blood cell counts were analyzed 4 hours after steroid administration.

Main Results:

• Monocyte chemotaxis, bacterial killing, phagocytosis, and oil phagocytosis were not significantly altered by the steroid dose.
• Asthma patients exhibited monocytopenia, lymphopenia, and neutrophilia 4 hours after steroid administration.
• No significant impairment in key monocyte functions was observed.

Conclusions:

• Alternate-day steroid therapy at the studied dose does not impair critical monocyte functions.
• Transient changes in circulating leukocyte counts occur post-steroid administration.
• This supports the clinical observation of a low incidence of serious infections in patients on such regimens.